A Randomized, Double-Blind, Active-Comparator-Controlled, Parallel-Group Study to Evaluate the Safety of Etoricoxib in Patients With Osteoarthritis or Rheumatoid Arthritis.
Latest Information Update: 05 May 2022
At a glance
- Drugs Etoricoxib (Primary) ; Diclofenac
- Indications Arthritis; Musculoskeletal pain; Osteoarthritis; Rheumatoid arthritis
- Focus Adverse reactions; Registrational
- Acronyms MEDAL
- Sponsors Organon
- 14 Nov 2006 Status change
- 19 Jul 2005 New trial record.